Pharmaceutical composition for treating respiratory diseases

A technology for respiratory diseases and compositions, applied in the direction of respiratory diseases, drug combinations, active ingredients of hydroxyl compounds, etc., can solve side effects, can not cure asthma and other problems, achieve the effects of no toxic side effects, significant curative effect, and broad market prospects

Inactive Publication Date: 2016-01-13
泸州医学院附属中医医院
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Long-term high-dose inhaled steroids and oral steroids c...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] The preparation of embodiment 1 pharmaceutical composition of the present invention

[0020] Take the raw materials according to the following weight ratio:

[0021] Stir-fried white mustard seeds 1g, Corydalis 2g, Kansui 2g, Asarum 2g, Borneol 0.5g, Bamboo Lek 4g, Dried ginger 1g.

[0022] The preparation method is as follows:

[0023] Weigh each medicinal material, clean, dry, pulverize, pass through a 100-mesh sieve, stir, mix evenly, place in a dry container, and seal for later use.

Embodiment 2

[0024] The preparation of embodiment 2 pharmaceutical compositions of the present invention

[0025] Take the raw materials according to the following weight ratio:

[0026] White Mustard Seed 1g, Corydalis Corydalis 1g, Kansui 1g, Asarum 0.5g, Borneol 0.5g, Bamboo Lek 2g, Dried Ginger 0.5g.

[0027] The preparation method is as follows:

[0028] Weigh each medicinal material, clean, dry, pulverize, pass through a 100-mesh sieve, stir, mix evenly, place in a dry container, and seal for later use.

[0029] The preparation of embodiment 2 pharmaceutical compositions of the present invention

[0030] Take the raw materials according to the following weight ratio:

[0031] White Mustard Seed 3g, Corydalis Corydalis 4g, Kansui 4g, Asarum 3g, Borneol 1g, Bamboo Lek 6g, Dried Ginger 3g.

[0032] The preparation method is as follows:

[0033] Weigh each medicinal material, clean, dry, pulverize, pass through a 100-mesh sieve, stir, mix evenly, place in a dry container, and seal f...

experiment example 1

[0035] Experimental Example 1 The clinical experiment of the pharmaceutical composition of the present invention for the treatment of bronchial asthma

[0036] 1. Materials and methods

[0037] 1.1 General information

[0038] A total of 108 patients who met the inclusion criteria were collected.

[0039] 1.2. Diagnostic criteria for bronchial asthma

[0040] TCM diagnostic criteria: Refer to the "Guidelines for Diagnosis and Treatment of Common Diseases in Internal Medicine of Traditional Chinese Medicine" (ZYYXH / T5-2008) issued by the China Association of Traditional Chinese Medicine.

[0041] (1) When the attack occurs, there is a wheezing sound in the throat, dyspnea, and even opening the mouth and lifting the shoulders, unable to lie on the back, or cyanosis of the lips and nails.

[0042] (2) It is recurrent, often induced by factors such as sudden changes in climate, improper diet, emotional disorders, and fatigue. Before the attack, there are many symptoms such as ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a pharmaceutical composition for treating respiratory diseases. The pharmaceutical composition contains the following raw materials in parts by weight: 1-3 parts of semen brassicae, 1-4 parts of rhizoma corydalis, 1-4 parts of euphorbia kansui, 0.5-3 parts of asarum, 0.5-1 part of borneol, 2-6 parts of bamboo juice and 0.5-3 parts of dried ginger. The invention also provides a preparation method and an application of the pharmaceutical composition. The pharmaceutical composition provided by the invention is remarkable in curative effect, has the total effective rate of 82.10% and has a wide market prospect; and the invention provides a novel drug which is efficient, safe, free of toxic or side effect and suitable for being taken for a long term and is used for clinically treating bronchial asthma.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating respiratory diseases, a preparation method and application thereof, and belongs to the field of medicines. Background technique [0002] Respiratory system disease is a common and frequently-occurring disease. The main lesions are in the trachea, bronchi, lungs, and chest cavity. Mild cases often cause coughing, chest pain, and respiratory problems. Severe cases have dyspnea, hypoxia, and even death due to respiratory failure. The death rate in the city is the third, while in the countryside it is the first. What should be paid more attention to is that due to air pollution, smoking, population aging and other factors, chronic obstructive pulmonary disease (referred to as COPD, including chronic bronchitis, emphysema, pulmonary heart disease), bronchial asthma, lung cancer, The morbidity and mortality of diseases such as pulmonary diffuse interstitial fibrosis and pulmonary infection h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9068A61P11/00A61P11/10A61P11/14A61P11/06A61K31/045
Inventor 闫爵王莹王锋黄锐吴晓罗婧王伟刘华辉
Owner 泸州医学院附属中医医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products